TAX-TORC: A phase I trial of the combination of AZD2014 (dual mTORC1/mTORC2 inhibitor) and weekly paclitaxel in patients with solid tumors.
Desamparados Roda
No relevant relationships to disclose
Han Hsi Wong
No relevant relationships to disclose
Elena Geuna
No relevant relationships to disclose
Saeed Rafii
No relevant relationships to disclose
Ruth Ruddle
No relevant relationships to disclose
Angela Hayes
No relevant relationships to disclose
Karen E Swales
No relevant relationships to disclose
Sarah Jane Stimpson
No relevant relationships to disclose
Nitharsan Sathiyayogan
No relevant relationships to disclose
Nina Tunariu
No relevant relationships to disclose
Alison Joanne Turner
No relevant relationships to disclose
Emma Hall
No relevant relationships to disclose
Timothy Anthony Yap
No relevant relationships to disclose
Susana N. Banerjee
No relevant relationships to disclose
Mary E.R. O'Brien
No relevant relationships to disclose
L Rhoda Molife
No relevant relationships to disclose
Stan B Kaye
No relevant relationships to disclose
Johann Sebastian De Bono
Consultant or Advisory Role - AstraZeneca
Bristi Basu
No relevant relationships to disclose
Udai Banerji
No relevant relationships to disclose